their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
product quality (the company has been awarded ISO 13485, the Quality Management System for Medical Device Industry), which is an important tool in the competition and expansion of the market in the future
name="viewport">` in some cases. @at-root { @-ms-viewport { width: device-width; } } // stylelint-disable selector-list-comma-newline-after // Shim for "new" HTML5 structural elements to display
name="viewport">` in some cases. @at-root { @-ms-viewport { width: device-width; } } // stylelint-disable selector-list-comma-newline-after // Shim for "new" HTML5 structural elements to display
to secure adequate funding to repay a large amount of outstanding trade debt, especially the trade debt owed to Cargill International Trading Pte. Ltd. (“Cargill”) in the amount of USD 105 million
holders of the Company/ operating revenue 3 Net Profit (Annualised) / Average Total Shareholders’ equity (average of outstanding at end of the previous year and at end of this year) 4 Earnings before
account receivables in amount of 23.8 Mb. However, in 2019 the company have appointed a new distributor in Cambodia using cash basic Payment to avoid long overdue outstanding receivable or allowance of bad
outstanding loan of 60 million baht. Due to The Company needed to use loan for working capital and requested to extend the loan 60 Million Baht as the following details: 1. Date of transaction occurs : 1
outstanding balance of debentures in the amount of Baht 380.20 million since the 1st quarter of 2019. Shareholders’ Equity as of December 31, 2019 was Baht 1,454.41 million increasing slightly from 1,447.32